Mesenteric panniculitis: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
*Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref> | *Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref> | ||
*A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>. | *A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)<ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref>. | ||
* | *Occurs independently (specific cause unknown) or in association with other disorders <ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref> | ||
==Clinical Features== | ==Clinical Features== | ||
| Line 15: | Line 15: | ||
==Management== | ==Management== | ||
*Supportive ED treatment | *Supportive ED treatment | ||
There is no standardized treatment, and it may consist of anti-inflammatory or immunosuppressive agents. We recommend resection only when the advanced inflammatory changes become irreversible or in cases of bowel obstruction | |||
*Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine) | *Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine) | ||
==Disposition== | ==Disposition== | ||
*Outpatient | *Outpatient | ||
==Prognosis== | |||
*Overall prognosis is usually good and recurrence seems to be rare <ref>Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.</ref> | |||
==See Also== | ==See Also== | ||
Revision as of 17:16, 27 June 2017
Background
- Also known as sclerosing mesenteritis, mesenteric lipodystrophy, mesenteric sclerosis, retractile mesenteritis, mesenteric Weber-Christian disease, liposclerotic mesenteritis, lipomatosis and lipogranuloma of the mesentery[1]
- A rare, benign, and chronic fibrosing inflammatory disease that affects the adipose tissue of the mesentery (of the small intestine and colon)[2].
- Occurs independently (specific cause unknown) or in association with other disorders [3]
Clinical Features
Differential Diagnosis
Evaluation
- Regional increase in mesenteric fat density on abdominal CT (i.e. “misty mesentery”)
- May be confirmed by surgical biopsy
Management
- Supportive ED treatment
There is no standardized treatment, and it may consist of anti-inflammatory or immunosuppressive agents. We recommend resection only when the advanced inflammatory changes become irreversible or in cases of bowel obstruction
- Chronic treatment includes workup of underlying etiology and consideration of medical therapy for severe/protracted disease (e.g. corticosteroids, cyclophosphamide, or azathioprine)
Disposition
- Outpatient
Prognosis
- Overall prognosis is usually good and recurrence seems to be rare [4]
See Also
External Links
References
- ↑ Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.
- ↑ Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.
- ↑ Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.
- ↑ Issa I and Baydoun H. Mesenteric panniculitis: Various presentations and treatment regimens. World J Gastroenterol. 2009 Aug 14; 15(30): 3827–3830.